BLU-285,
Avapritinib,
1703793-34-3,
UNII-513P80B4YJ,
513P80B4YJ,
(1S)-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamine,
Avapritinib [INN],
Avapritinib (BLU-285),
BLU-285 (Avapritinib),
SCHEMBL16652297,
BCP20175,
EX-A1366,
MFCD31544325,
ACN-051245,
CS-7577,
HY-101561,
AK00739613,
(S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethan-1-amine,
(S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethanamine,